Skip to Content

Colestipol

In the US, Colestipol (colestipol systemic) is a member of the drug class bile acid sequestrants and is used to treat Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL and Hyperlipoproteinemia Type IIb - Elevated LDL VLDL.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AC02

CAS registry number (Chemical Abstracts Service)

0026658-42-4

Therapeutic Category

Lipid lowering agent: Bile acid sequestrant

Chemical Name

Copolymer of dietylenetriamine and 1-chloro-2,3-epoxypropane

Foreign Names

  • Colestipolum (Latin)
  • Colestipol (German)
  • Colestipol (French)
  • Colestipol (Spanish)

Generic Names

Brand Names

  • Colestid
    Farmea, Israel; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Spain; Pfizer, United Kingdom; Pfizer, New Zealand; Pharmacia & Upjohn, United States
  • Lestid
    Pfizer, Denmark; Pfizer, Norway; Pfizer, Sweden

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide